Actionable genomic information for accurate diagnosis for metastatic patients with diagnostic ambiguity.

An accurate tumor type diagnosis is the first step in precision oncology.

Highlights:

Distinguishes between 50 tumor types

Identifies tumor types not previously considered

Most widely adopted gene expression test for diagnosis of unknown or uncertain tumors

Requires small tumor sample (~300 cells)

Treatment recommendations changed in 47% of patients based on incorporation of test results (more)^

Test results available within 5 business days
      (from receipt of specimen and required information)

Most validated gene expression test

100% covered by Medicare

Helping 7,500 physicians and 32,000 metastatic patients for over 8 years

 

 

^ NeoTYPE Cancer Profiles are performed and billed separately by our contracted reference laboratory, NeoGenomics Laboratories, Inc.

 

Laboratory photo Couple photo Photo of physician listening to patient